z-logo
open-access-imgOpen Access
Management for Nonmalignant Primary Tumors of the Nasal Cavity
Author(s) -
Hashimoto Shigehisa,
Takahashi Sugata T.
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811415823a414
Subject(s) - medicine , angiofibroma , hemangioma , magnetic resonance imaging , radiology , nasal cavity , endoscopy , papilloma , embolization , benign tumor , surgery , pathology
Objective Assess the treatment strategy for nonmalignant primary tumors of the nasal cavity. Method The subjects were 41 patients who underwent surgery for nonmalignant tumors of the nasal cavity during the 3 years. An endoscopic examination, contrast‐enhanced computed tomography (CT), and magnetic resonance imaging (MRI) were performed preoperatively, and all of the patients were treated surgically. Results The diagnosis was papilloma in 21 cases, hemangioma in 15 cases, juvenile angiofibroma in 3 cases, and leiomyoma in 2 cases. For patients diagnosed with papilloma by endoscopy and CT, additional MRI was performed to identify the tumor base. Computer‐aided surgery was used, and the tumor was endoscopically resected. Because blood flow was sufficient in cases of hemangiomas or angiofibromas, preoperative embolization was performed in 2 cases. Although external incision was anticipated in some cases, endoscopic resection of tumors was possible in all cases, and none of the patients required transfusions. Conclusion It was possible to make the differential diagnosis between papilloma and hemangioma/angiofibroma on the basis of the preoperative endoscopic and CT findings. Safe and reliable resection was possible by combined use of MRI and computer‐aided surgery for the papillomas, and use of embolization for the hemangiomas and angiofibromas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here